Improved therapeutic effect against leukemia by a combination of chaetocin and a HDAC inhibitor trichostain A was reported previously.30 However, trichostain A is not considered as a therapeutic drug due to high toxicity. This evidence concerns the gene HDAC9 and leukemia.